ABBV · NYSE · Healthcare · Drug Manufacturers - General

AbbVie

—Past month
Price unavailable
  • 52W range190.75–269.39
  • P/E ratio74.89
  • Market cap467.55B

Latest news

Loading...

About

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patient...

abbvie.com